Symbol="BOLT"
AssetType="Common Stock"
Name="Bolt Biotherapeutics"
Description="Bolt Biotherapeutics, Inc., a clinical-stage immuno-oncology company, is dedicated to the discovery, development and commercialization of pharmaceutical products. The company is headquartered in Redwood city, California."
CIK="1641281"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="900 CHESAPEAKE DRIVE, REDWOOD CITY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="43485300"
EBITDA="-79807000"
PERatio="None"
PEGRatio="None"
BookValue="3.745"
DividendPerShare="0"
DividendYield="0"
EPS="-2.09"
RevenuePerShareTTM="0.18"
ProfitMargin="0"
OperatingMarginTTM="-12.04"
ReturnOnAssetsTTM="-0.226"
ReturnOnEquityTTM="-0.439"
RevenueTTM="6782000"
GrossProfitTTM="1620000"
DilutedEPSTTM="-2.09"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.029"
AnalystTargetPrice="5.2"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="10.3"
PriceToBookRatio="0.27"
EVToRevenue="270.65"
EVToEBITDA="1.024"
Beta="0.859"
num_52WeekHigh="2.03"
num_52WeekLow="1.12"
num_50DayMovingAverage="1.372"
num_200DayMovingAverage="1.452"
SharesOutstanding="37813300"
DividendDate="None"
ExDividendDate="None"
symbol="BOLT"
open="1.13"
high="1.17"
low="1.12"
price="1.15"
volume="83260.00"
latest_trading_day="2023-08-18"
previous_close="1.14"
change="0.01"
change_percent="0.8772%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="67"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="33"
Volume_recent_avg="173371"
Change_recent_avg="0.01"
Delta_recent_avg="0.1"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-0.32"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="33"
Aroon_momentum_negative="67"
image_negative_thumbnail_id_1="1098"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0131.jpeg"
image_negative_thumbnail_id_2="173"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0003.jpeg"
image_neutral_thumbnail_id_1="561"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0038.jpeg"
image_neutral_thumbnail_id_2="538"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0061.jpeg"
image_positive_thumbnail_id_1="673"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0035.jpeg"
image_positive_thumbnail_id_2="634"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0074.jpeg"
image_professor_thumbnail_id_1="1171"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
image_professor_thumbnail_id_2="1172"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
